Does Rallies show 13F holders for BRKR?

Yes. Rallies tracks hedge fund and 13F ownership data for BRKR, including fund names, share counts, latest tracked quarter, and position changes when available.

Is BRKR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BRKR. It does not provide personalized investment advice.

BRKR (Bruker Corporation) Stock Analysis - Hedge Fund Holdings

Bruker Corporation (BRKR) is a publicly traded Healthcare sector company. As of May 20, 2026, BRKR trades at $44.76 with a market cap of $6.51B and a P/E ratio of -182.83. BRKR moved +3.87% today. Year to date, BRKR is -13.64%; over the trailing twelve months it is +15.89%. Its 52-week range spans $28.53 to $72.94. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces BRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns BRKR stock?

Hedge funds tracked by Rallies that own BRKR include Sculptor Capital, Orbimed Advisors, Glenview Capital, Scion Asset, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bruker Corporation.

BRKR Key Metrics

Key financial metrics for BRKR
Metric	Value
Price	$44.76
Market Cap	$6.51B
P/E Ratio	-182.83
EPS	$-0.24
Dividend Yield	0.05%
52-Week High	$72.94
52-Week Low	$28.53
Volume	1.62M
Avg Volume	0
Revenue (TTM)	$3.46B
Net Income	$-9.40M
Gross Margin	45.29%

Top Hedge Funds Holding BRKR

Sculptor Capital holds 3.27M shares of BRKR, changed +9.00% as of Mar 31, 2026.
Orbimed Advisors holds 555.79K shares of BRKR, changed +0.00% as of Dec 31, 2025.
Glenview Capital holds 319.67K shares of BRKR, changed +0.00% as of Sep 30, 2025.
Scion Asset holds 250.00K shares of BRKR, changed +233.33% as of Jun 30, 2025.
Mangrove Partners holds 14.59K shares of BRKR, changed +0.00% as of Sep 30, 2024.

Latest BRKR News

Bruker jumps as Q1 revenue and adjusted EPS beat estimates, FY26 outlook reaffirmed — May 6, 2026
Bruker jumps 3.5% as traders position ahead of May 6 Q1 earnings — May 5, 2026
Bruker jumps as traders position ahead of May 6 Q1 earnings catalyst — Apr 30, 2026
Bruker falls as investors brace for May 6 Q1 earnings update — Apr 29, 2026
Bruker drops as weak 2026 organic-growth outlook outweighs profit expansion plan — Apr 23, 2026

Recent BRKR Insider Trades

Munch Mark sold 2.00K (~$79.80K) on Apr 15, 2026.
Munch Mark sold 2.00K (~$70.88K) on Mar 13, 2026.
Munch Mark sold 2.00K (~$73.88K) on Feb 13, 2026.

BRKR Analyst Consensus

7 analysts cover BRKR: 0 strong buy, 3 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.00.

Common questions about BRKR

Who owns BRKR stock?: Hedge funds tracked by Rallies that own BRKR include Sculptor Capital, Orbimed Advisors, Glenview Capital, Scion Asset, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Bruker Corporation.
Does Rallies show 13F holders for BRKR?: Yes. Rallies tracks hedge fund and 13F ownership data for BRKR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is BRKR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BRKR. It does not provide personalized investment advice.